ernstlaboratory.bsky.social
@ernstlaboratory.bsky.social
Research is our game: scientists aiming to understand stem cells and leukemia to benefit health
For our local Colorado cancer researchers @cucancercenter.bsky.social @nucleosomepolice.bsky.social @cucancerbio.bsky.social
January 16, 2026 at 1:30 PM
For our local Colorado cancer researchers @cucancercenter.bsky.social @nucleosomepolice.bsky.social @cucancerbio.bsky.social
Ok, I got my own answer, use html coding to get formatting into your personal statement part: www.markdownguide.org/basic-syntax/
January 16, 2026 at 1:21 PM
Ok, I got my own answer, use html coding to get formatting into your personal statement part: www.markdownguide.org/basic-syntax/
Reposted by ernstlaboratory.bsky.social
Very early days, but delighted that our recent review on reevaluation of aging hematopoiesis published in Experimental Hematology, official journal of @isehsociety.bsky.social is classified as highly cited by web of science. Open access here: www.exphem.org/article/S030...
Reconsidering the usual suspects in age-related hematologic disorders: is stem cell dysfunction a root cause of aging?
The global trend toward an increasing aged population demographic raises significant
societal challenges, particularly concerning health. As organisms age, progressive
tissue dysfunction increases the...
www.exphem.org
January 15, 2026 at 10:31 AM
Very early days, but delighted that our recent review on reevaluation of aging hematopoiesis published in Experimental Hematology, official journal of @isehsociety.bsky.social is classified as highly cited by web of science. Open access here: www.exphem.org/article/S030...
I don't think that works for official uses-have you done the one where you have to certify that you don't cavort with foreigners of malign talent recruitment programs (whatever that means)?
I don't trust the PDF. I've previously downloaded it in Word, and then done a ton of formatting to get it right.
December 29, 2025 at 3:31 AM
I don't think that works for official uses-have you done the one where you have to certify that you don't cavort with foreigners of malign talent recruitment programs (whatever that means)?
Anyone have good instructions/pointers for making biosketches on SciENcv in its current format? My info is there, yet when I try to download the pdf it looks all jumbled....
December 28, 2025 at 9:20 PM
Anyone have good instructions/pointers for making biosketches on SciENcv in its current format? My info is there, yet when I try to download the pdf it looks all jumbled....
Also one of the BEST #ASH2025 talks in my opinion was from Nancy Speck! Huge fan club up front, and an amazing presentation featuring a career boldly stepping into so many directions that impact hematology!
December 9, 2025 at 4:29 PM
Also one of the BEST #ASH2025 talks in my opinion was from Nancy Speck! Huge fan club up front, and an amazing presentation featuring a career boldly stepping into so many directions that impact hematology!
One of my favorite pics of the Myeloid Workshop at #ASH2025. Not at all challenging to find female speakers; thanks to ASH and the excellent section leaders for making this happen!
December 9, 2025 at 4:25 PM
One of my favorite pics of the Myeloid Workshop at #ASH2025. Not at all challenging to find female speakers; thanks to ASH and the excellent section leaders for making this happen!
@paralkarlab.bsky.social
Hello, since you are a hematology/oncology influencer, could you re-post my thing about the Myeloid Workshop being on despite ASH not getting it up on the website? Thank you!
Hello, since you are a hematology/oncology influencer, could you re-post my thing about the Myeloid Workshop being on despite ASH not getting it up on the website? Thank you!
November 4, 2025 at 11:43 PM
@paralkarlab.bsky.social
Hello, since you are a hematology/oncology influencer, could you re-post my thing about the Myeloid Workshop being on despite ASH not getting it up on the website? Thank you!
Hello, since you are a hematology/oncology influencer, could you re-post my thing about the Myeloid Workshop being on despite ASH not getting it up on the website? Thank you!
Important PSA! ASH Scientific Workshop website is experiencing a technical problem; YES, the Myeloid Workshop should be on the website and has an excellent speaker lineup already, stay tuned! @steidluli.bsky.social
November 2, 2025 at 6:10 PM
Important PSA! ASH Scientific Workshop website is experiencing a technical problem; YES, the Myeloid Workshop should be on the website and has an excellent speaker lineup already, stay tuned! @steidluli.bsky.social
I hate to make this even more popular than it already is, but...had a really great experience. Cells on Thursday, results on Sunday..nice platform for data analysis too
Learn more at plasmidsaurus.com/rna
November 2, 2025 at 5:44 PM
I hate to make this even more popular than it already is, but...had a really great experience. Cells on Thursday, results on Sunday..nice platform for data analysis too
Reposted by ernstlaboratory.bsky.social
In a Flint Animal Cancer Center canine clinical trial, they are testing a novel combination of orally delivered drugs targeting metastasis-promoting white blood cells (WBC), in combination with reprogramming the patient’s cancer fighting WBC to seek out and destroy osteosarcoma.
September 30, 2025 at 4:47 PM
In a Flint Animal Cancer Center canine clinical trial, they are testing a novel combination of orally delivered drugs targeting metastasis-promoting white blood cells (WBC), in combination with reprogramming the patient’s cancer fighting WBC to seek out and destroy osteosarcoma.
So jealous. ANA is the best too.
Excited to be heading out to #ISEH2025 in Kumamoto @isehsociety.bsky.social
September 23, 2025 at 1:13 PM
So jealous. ANA is the best too.
Reposted by ernstlaboratory.bsky.social
@eirinipapapetrou.bsky.social from the Icahn School of Medicine at Mount Sinai is excited for the rooftop party after the iPSC symposium the day before #ISEH2025 🏯 begins 🌃 Learn more about this event and register! sites.google.com/view/2025ips...
September 9, 2025 at 4:44 PM
@eirinipapapetrou.bsky.social from the Icahn School of Medicine at Mount Sinai is excited for the rooftop party after the iPSC symposium the day before #ISEH2025 🏯 begins 🌃 Learn more about this event and register! sites.google.com/view/2025ips...
Reposted by ernstlaboratory.bsky.social
Take advantage of the chance to see your international friends like Hitoshi Takizawa, PhD from Kumamoto University will be doing at #ISEH2025 🏯. Register for the meeting here: www.iseh.org/2025Registration
September 13, 2025 at 3:45 PM
Take advantage of the chance to see your international friends like Hitoshi Takizawa, PhD from Kumamoto University will be doing at #ISEH2025 🏯. Register for the meeting here: www.iseh.org/2025Registration
Lucky you!
Super excited to attend the 54th @isehsociety.bsky.social
conference in Japan next week! First time in Japan. First time at a hematology conference. Great chance to network with the world's best and share our CH work in Down Syndrome.
@crnicinstitute.bsky.social @cuanschutz.bsky.social
conference in Japan next week! First time in Japan. First time at a hematology conference. Great chance to network with the world's best and share our CH work in Down Syndrome.
@crnicinstitute.bsky.social @cuanschutz.bsky.social
September 22, 2025 at 11:26 PM
Lucky you!
This is really cool. I have had a fantasy of knocking out pol II since the 90s, so it is really nice to see it finally done and thoroughly analyzed.
Extremely proud to share the impressive work done by Anouk Olthof et al. on how cells maintain healthy levels of RNAPII, and how they respond when levels are too low. Fascinating stuff, we think www.biorxiv.org/content/10.1...
Systems-level feedback loops maintain gene expression homeostasis following RNA polymerase II dosage perturbation
Transcription is regulated by sequence-specific transcription factors and enzymes allowing access to genes in chromatin. However, recent data indicate that the abundance of RNA polymerase II (RNAPII) ...
www.biorxiv.org
September 19, 2025 at 2:10 PM
This is really cool. I have had a fantasy of knocking out pol II since the 90s, so it is really nice to see it finally done and thoroughly analyzed.
Thank you so much!
Hill Day ready! 💪👏 ASH Advocacy Leadership Institute participants prepped to advocate for the Sickle Cell Disease Care Act & NIH funding to support lifesaving blood disorder research. Tomorrow, they take their message to Capitol Hill.
Join the fight: https://bit.ly/3YeapvY
#Fight4Hematology
Join the fight: https://bit.ly/3YeapvY
#Fight4Hematology
September 9, 2025 at 12:19 AM
Thank you so much!
and MCO members...@cucancercenter.bsky.social
Yeah Varuna's thesis work is out!!!!! congratulations Varuna and Sabrina et al
New experiments in #ScienceSignaling have uncovered how melanoma and other types of cancer cells can evade therapies by relying on a cell cycle protein—a discovery that could inform more effective combination therapies for these hardy tumors. https://scim.ag/41yQYQf
September 8, 2025 at 4:34 PM
and MCO members...@cucancercenter.bsky.social
Yeah Varuna's thesis work is out!!!!! congratulations Varuna and Sabrina et al
New experiments in #ScienceSignaling have uncovered how melanoma and other types of cancer cells can evade therapies by relying on a cell cycle protein—a discovery that could inform more effective combination therapies for these hardy tumors. https://scim.ag/41yQYQf
MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells
Cyclin D1 accumulation enables a switch in melanoma cells from drug-induced quiescence to proliferation.
scim.ag
September 5, 2025 at 8:12 PM
Yeah Varuna's thesis work is out!!!!! congratulations Varuna and Sabrina et al
Reposted by ernstlaboratory.bsky.social
New experiments in #ScienceSignaling have uncovered how melanoma and other types of cancer cells can evade therapies by relying on a cell cycle protein—a discovery that could inform more effective combination therapies for these hardy tumors. https://scim.ag/41yQYQf
MAPK and mTORC1 signaling converge to drive cyclin D1 protein production to enable cell cycle reentry in melanoma persister cells
Cyclin D1 accumulation enables a switch in melanoma cells from drug-induced quiescence to proliferation.
scim.ag
September 5, 2025 at 3:00 PM
New experiments in #ScienceSignaling have uncovered how melanoma and other types of cancer cells can evade therapies by relying on a cell cycle protein—a discovery that could inform more effective combination therapies for these hardy tumors. https://scim.ag/41yQYQf
Reposted by ernstlaboratory.bsky.social
We have new members! Welcome to the CU Cancer Center! 👏
August 17, 2025 at 12:58 AM
We have new members! Welcome to the CU Cancer Center! 👏
Congratulations @mary-flores.bsky.social! what an honor for the lab too @chrmosimann.bsky.social
I’m honored to be selected as a Pew Latin American Fellow 2025! 🐟🧬🔬
With this opportunity, I will continue my postdoctoral training in the @chrmosimann.bsky.social lab at @cupediatrics.bsky.social/ @cudevbio.bsky.social , and it opens the door for me to return and established a lab in LATAM. 🇲🇽😍
With this opportunity, I will continue my postdoctoral training in the @chrmosimann.bsky.social lab at @cupediatrics.bsky.social/ @cudevbio.bsky.social , and it opens the door for me to return and established a lab in LATAM. 🇲🇽😍
August 13, 2025 at 12:33 PM
Congratulations @mary-flores.bsky.social! what an honor for the lab too @chrmosimann.bsky.social